Alza, U.S. Bioscience deal

AZA will purchase 4.9 percent of UBS for $21.5 million through the purchase

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE